Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple body wash and cream soothe eczema without a prescription?

NCT ID NCT07700745

Symptom relief Sponsor: Rejuvaskin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This trial tests whether a daily routine using Rejuvaskin Eczema Body Wash followed by Skin Recovery Cream can improve dryness, roughness, itch, and irritation in adults with eczema-prone skin. Thirty-five participants aged 18 to 65 use the products once daily for 4 weeks and report their symptoms through a remote app. The study is single-arm and open-label, meaning everyone gets the same treatment and knows what they are using.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Rejuvaskin Eczema Body Wash and Skin Recovery Cream (dietary supplement-based skincare products)
What this could lead to
If the products prove effective, they could offer a gentle, over-the-counter option for managing eczema symptoms like dryness and itch.
What could go wrong
This is a small, single-arm study with no placebo group, so results may be influenced by the placebo effect. The products are dietary supplements, not FDA-approved drugs, and long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 35 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult women or men aged 18-65 years. * Self-reported symptoms of eczema or eczema-prone skin (e.g., dryness, roughness, itching, irritation on the body). * Visible signs of eczema such as dryness, roughness, or irritation on at least one part of the body at the time of enrollment. * Willing to use Rejuvaskin Eczema Body Wash once daily as their primary body cleanser for 4 consecutive weeks. * Willing to use Rejuvaskin Skin Recovery Cream once daily after using the - Rejuvaskin body cleanser for 4 consecutive weeks. * Willing to maintain their current diet, skincare routine (aside from substitution of body wash and skin cream), and lifestyle habits for the study duration. * Willing and able to take standardized photographs of an affected body area at Baseline and Week 4 using a personal smartphone. * Able to read, understand, and complete questionnaires in English. * Resides in the United States with a valid shipping address. * Willing to provide informed consent and comply with all study procedures Exclusion Criteria: * Known allergy or sensitivity to any ingredient in the study product. * Currently pregnant, breastfeeding, or planning to become pregnant during the study period. * Active, severe skin condition on the body requiring prescription topical or systemic treatment (e.g., active severe atopic dermatitis flare under medical care, active infection at intended application sites). * Currently using prescription topical corticosteroids, calcineurin inhibitors, or other prescription topical eczema treatments on the body, or initiation of such treatment planned during the study. * Currently participating in another clinical or skincare research study, or planning to enroll during this study's duration. (

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atopic dermatitis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atopic eczema Eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Atopic dermatitis Eczema Eczema-prone skin

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.